Ken Griffin Medical Devices

Citadel Advisors LLC

$618 Billion
Q3 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$147B	$870 Million 0.14% of portfolio	8,906,245	Q3 2025 Added 64.8%
DXCM Dexcom Inc	$22.4B	$456 Million 0.07% of portfolio	6,778,490	Q3 2025 Added 395.24%
MDT Medtronic PLC	$128B	$353 Million 0.06% of portfolio	3,701,475	Q3 2025 Reduced 62.22%
EW Edwards Lifesciences Corp	$53.4B	$329 Million 0.05% of portfolio	4,234,570	Q3 2025 Reduced 66.74%
PEN Penumbra Inc	$10.6B	$246 Million 0.04% of portfolio	970,998	Q3 2025 Added 343.39%
SYK Stryker Corp	$136B	$136 Million 0.02% of portfolio	367,788	Q3 2025 New
INSP Inspire Medical Systems, Inc.	$2.49B	$130 Million 0.02% of portfolio	1,748,409	Q3 2025 Added 20,054.57%
PODD Insulet Corp	$23.1B	$109 Million 0.02% of portfolio	352,443	Q3 2025 Reduced 54.32%
ABT Abbott Laboratories	$228B	$78.5 Million 0.01% of portfolio	585,801	Q3 2025 New

STE Steris PLC	$25.8B	$51 Million 0.01% of portfolio	206,300	Q3 2025 Added 97.68%
BRKR Bruker Corp	$6.17B	$42.7 Million 0.01% of portfolio	1,315,634	Q3 2025 Reduced 51.5%
ITGR Integer Holdings Corp	$2.3B	$31.9 Million 0.01% of portfolio	309,179	Q3 2025 Reduced 28.83%
ALGN Align Technology Inc	$10.7B	$23.1 Million 0.0% of portfolio	184,591	Q3 2025 Reduced 88.97%
PHG Koninklijke Philips Nv	$25.4B	$18.5 Million 0.0% of portfolio	677,686	Q3 2025 Added 1,130.12%
BIO Bio Rad Laboratories, Inc.	$7.71B	$14.1 Million 0.0% of portfolio	50,306	Q3 2025 Added 1,821.54%
TMDX Trans Medics Group, Inc.	$3.66B	$14 Million 0.0% of portfolio	124,917	Q3 2025 Reduced 20.15%
SMLR Semler Scientific, Inc.	$156M	$11.7 Million 0.0% of portfolio	403,275	Q3 2025 Reduced 34.67%
RXST Rx Sight, Inc.	$269M	$11.6 Million 0.0% of portfolio	1,290,144	Q3 2025 Added 25.52%

ZBH Zimmer Biomet Holdings, Inc.	$18.9B	$11.4 Million 0.0% of portfolio	116,146	Q3 2025 New
SRDX Surmodics Inc	$583M	$10.9 Million 0.0% of portfolio	365,110	Q3 2025 Added 485.55%
INMD In Mode Ltd.	$1.18B	$8.9 Million 0.0% of portfolio	597,147	Q3 2025 Added 104.07%
AVNS Avanos Medical, Inc.	$529M	$6.64 Million 0.0% of portfolio	574,104	Q3 2025 Added 194.83%
GMED Globus Medical Inc	$6.51B	$6.42 Million 0.0% of portfolio	112,093	Q3 2025 New
SIBN Si Bone, Inc.	$598M	$5.21 Million 0.0% of portfolio	354,244	Q3 2025 Reduced 11.33%
BFLY Butterfly Network, Inc.	$367M	$5.19 Million 0.0% of portfolio	2,688,373	Q3 2025 Reduced 0.64%
DCTH Delcath Systems, Inc.	$76.8M	$4.83 Million 0.0% of portfolio	449,315	Q3 2025 Reduced 44.06%
GKOS Glaukos Corp	$4.29B	$4.56 Million 0.0% of portfolio	55,940	Q3 2025 Reduced 82.55%
LIVN Liva Nova PLC	$2.96B	$3.75 Million 0.0% of portfolio	71,655	Q3 2025 Reduced 61.18%
AORT Artivion, Inc.	$1.84B	$3.51 Million 0.0% of portfolio	82,852	Q3 2025 Reduced 45.9%
UFPT Ufp Technologies Inc	$1.75B	$3.4 Million 0.0% of portfolio	17,013	Q3 2025 Reduced 67.81%
PACB Pacific Biosciences Of California, Inc.	$362M	$3.2 Million 0.0% of portfolio	2,498,354	Q3 2025 New
VREX Varex Imaging Corp	$476M	$3.01 Million 0.0% of portfolio	242,553	Q3 2025 Reduced 57.6%
ATEC Alphatec Holdings, Inc.	$2.07B	$2.69 Million 0.0% of portfolio	184,892	Q3 2025 Added 9.95%
CNMD Conmed Corp	$1.28B	$2.59 Million 0.0% of portfolio	55,166	Q3 2025 Added 174.32%
IRMD Iradimed Corp	$1.06B	$2.4 Million 0.0% of portfolio	33,727	Q3 2025 Added 889.93%
SNN Smith & Nephew PLC	$14.2B	$2.03 Million 0.0% of portfolio	55,866	Q3 2025 Reduced 15.15%
CLPT Clear Point Neuro, Inc.	$379M	$1.88 Million 0.0% of portfolio	86,492	Q3 2025 Added 8.7%
IRTC I Rhythm Technologies, Inc.	$5.13B	$1.53 Million 0.0% of portfolio	8,892	Q3 2025 Reduced 91.11%
CERS Cerus Corp	$287M	$1.43 Million 0.0% of portfolio	899,598	Q3 2025 Reduced 12.59%
INGN Inogen Inc	$158M	$1.43 Million 0.0% of portfolio	174,458	Q3 2025 Added 7.88%
PRCT Procept Bio Robotics Corp	$1.32B	$1.31 Million 0.0% of portfolio	36,751	Q3 2025 Added 360.19%
MXCT Maxcyte, Inc.	$161M	$1.27 Million 0.0% of portfolio	803,066	Q3 2025 Reduced 21.89%
ARAY Accuray Inc	$100M	$1.07 Million 0.0% of portfolio	662,499	Q3 2025 New
BWAY Brainsway Ltd.	$262M	$1.07 Million 0.0% of portfolio	72,000	Q3 2025 Added 18.23%
SENS Senseonics Holdings, Inc.	$2.91B	$1.03 Million 0.0% of portfolio	2,337,853	Q3 2025 Added 83.11%
ZIMV Zim Vie Inc.	$495M	$811,000 0.0% of portfolio	42,829	Q3 2025 New
AXGN Axogen, Inc.	$1B	$790,000 0.0% of portfolio	44,308	Q3 2025 New
ELMD Electromed, Inc.	$214M	$755,000 0.0% of portfolio	31,166	Q3 2025 Added 15.57%
VMD Viemed Healthcare, Inc.	$244M	$723,000 0.0% of portfolio	108,589	Q3 2025 Reduced 25.1%
QIPT Quipt Home Medical Corp.	$81.1M	$667,000 0.0% of portfolio	256,680	Q3 2025 Added 81.36%

Shares Options

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Ken Griffin's portfolio

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account